Bringing GCP to the Imaging Suite ™
MedQIA is a full service imaging CRO that specializes in cutting edge Quantitative Image Analysis for clinical trials. What sets us apart is our ability to develop and validate novel imaging biomarkers for use in global, regulated clinical trials.
Latest News
April 3, 2012 New Publication by Dr. Matthew Brown, Chief Scientific Officer for MedQIA in the Journal of Nuclear Medicine Communications
Computer-aided quantitative bone scan assessment of prostate cancer treatment response
More than 90% of patients with advanced prostate cancer develop bone metastases, which can produce some of the most severe complications of the disease, including pain and spinal cord compromise. … more
March 14, 2012 Dr. Jonathan Goldin, Chief Medical Officer of MedQIA will present today at Bristol-Myers Squibb’s Day of Imaging
The Day of Imaging is designed to introduce participants to imaging technologies and specific applications in oncology, immuno-oncology, fibrosis and neuroscience. It is also a unique networking opportunity for speakers and participants alike to share knowledge about state-of-the-art imaging applications … more
March 5, 2012 Quantitative CT Imaging of the Lung Saturday, March 10, 2012 • Hyatt Regency Huntington Beach Huntington Beach, California
Program Description
This one-day course, co-sponsored by the Society of Thoracic Radiology and the Quantitative Imaging Biomarkers Alliance, with course directors Jonathan Goldin and David Lynch, will
summarize the current state of knowledge regarding the role of quantitative CT of … more
February 7, 2012
Come see Dr. Matthew Brown at SPIE 2012 in San Diego: Session 3: Oncology
Date: Tuesday 7 February
Time: 1:20 PM – 3:00 PM
Session Chairs: Matthew S. Brown, ; Axel Wismueller, Univ. of Rochester Medical Ctr.
Automatic detection of … more
All News
|
